 | • レポートコード：MRC2-11QY03883 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はマイコプラズマ診断のグローバル市場について調査・分析したレポートです。種類別（キット・試薬、機器、ソフトウェア・サービス）市場規模、用途別（病院、診断研究所、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別マイコプラズマ診断の競争状況、市場シェア ・世界のマイコプラズマ診断市場：種類別市場規模 2015年-2020年（キット・試薬、機器、ソフトウェア・サービス） ・世界のマイコプラズマ診断市場：種類別市場規模予測 2021年-2026年（キット・試薬、機器、ソフトウェア・サービス） ・世界のマイコプラズマ診断市場：用途別市場規模 2015年-2020年（病院、診断研究所、診療所、その他） ・世界のマイコプラズマ診断市場：用途別市場規模予測 2021年-2026年（病院、診断研究所、診療所、その他） ・北米のマイコプラズマ診断市場分析：米国、カナダ ・ヨーロッパのマイコプラズマ診断市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのマイコプラズマ診断市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のマイコプラズマ診断市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのマイコプラズマ診断市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Agilent Technologies, Inc、Thermo Fisher Scientific Inc、PromoCell GmbH、Charles River Laboratories International, Inc、Merck KGaA、Lonza Group、Takara Bio Inc (Takara Holding Company Inc.)、Savyon Diagnostics、Tecan Trading AG (Tecan Group)、Sartorius Stedim BioOutsource Limited、American Type Culture Collection (ATCC)、F Hoffmann-La Roche ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Mycoplasma diagnostics is a class of medical tests or examination conducted to evaluate nucleic acids or proteins at a molecular level. This aids in the early detection of mycoplasma contaminations in samples. Mycoplasma diagnostics is considered as a rapidly evolving and fast growing segment in the in-vitro diagnostic industry. Usually, usage of molecular diagnostics was limited due to necessity of vastly skilled specialists and high cost of tests.
Based on product, the global mycoplasma diagnostics market can be segmented into kits & reagents, instruments, and software & services. Of these, the kits & reagents segment dominated the market in 2016 and is expected to hold on to its lead through the forecast period. However, growth witnessed in the software & services segment is forecast to be higher in the coming years. The rising demand for automation in pharma, dianostics, and clinical sectors to realize the benefits of cost-effectiveness, will fuel application of mycoplasma diagnostics in these applications.
Market Analysis and Insights: Global Mycoplasma Diagnostics Market
The global Mycoplasma Diagnostics market size is projected to reach US$ 703.5 million by 2026, from US$ 660.6 million in 2020, at a CAGR of 6.0%% during 2021-2026.
Global Mycoplasma Diagnostics Scope and Market Size
Mycoplasma Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Mycoplasma Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Agilent Technologies, Inc
Thermo Fisher Scientific Inc
PromoCell GmbH
Charles River Laboratories International, Inc
Merck KGaA
Lonza Group
Takara Bio Inc (Takara Holding Company Inc.)
Savyon Diagnostics
Tecan Trading AG (Tecan Group)
Sartorius Stedim BioOutsource Limited
American Type Culture Collection (ATCC)
F Hoffmann-La Roche
Market segment by Type, the product can be split into
Kits & Reagents
Instruments
Software & Services
Market segment by Application, split into
Hospitals
Diagnostic Laboratories
Clinics
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Mycoplasma Diagnostics Revenue
1.4 Market by Type
1.4.1 Global Mycoplasma Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Kits & Reagents
1.4.3 Instruments
1.4.4 Software & Services
1.5 Market by Application
1.5.1 Global Mycoplasma Diagnostics Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Diagnostic Laboratories
1.5.4 Clinics
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Mycoplasma Diagnostics Market Perspective (2015-2026)
2.2 Global Mycoplasma Diagnostics Growth Trends by Regions
2.2.1 Mycoplasma Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Mycoplasma Diagnostics Historic Market Share by Regions (2015-2020)
2.2.3 Mycoplasma Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Mycoplasma Diagnostics Market Growth Strategy
2.3.6 Primary Interviews with Key Mycoplasma Diagnostics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Mycoplasma Diagnostics Players by Market Size
3.1.1 Global Top Mycoplasma Diagnostics Players by Revenue (2015-2020)
3.1.2 Global Mycoplasma Diagnostics Revenue Market Share by Players (2015-2020)
3.1.3 Global Mycoplasma Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Mycoplasma Diagnostics Market Concentration Ratio
3.2.1 Global Mycoplasma Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Mycoplasma Diagnostics Revenue in 2019
3.3 Mycoplasma Diagnostics Key Players Head office and Area Served
3.4 Key Players Mycoplasma Diagnostics Product Solution and Service
3.5 Date of Enter into Mycoplasma Diagnostics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Mycoplasma Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global Mycoplasma Diagnostics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Mycoplasma Diagnostics Market Size by Application (2015-2020)
5.2 Global Mycoplasma Diagnostics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Mycoplasma Diagnostics Market Size (2015-2020)
6.2 Mycoplasma Diagnostics Key Players in North America (2019-2020)
6.3 North America Mycoplasma Diagnostics Market Size by Type (2015-2020)
6.4 North America Mycoplasma Diagnostics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Mycoplasma Diagnostics Market Size (2015-2020)
7.2 Mycoplasma Diagnostics Key Players in Europe (2019-2020)
7.3 Europe Mycoplasma Diagnostics Market Size by Type (2015-2020)
7.4 Europe Mycoplasma Diagnostics Market Size by Application (2015-2020)
8 China
8.1 China Mycoplasma Diagnostics Market Size (2015-2020)
8.2 Mycoplasma Diagnostics Key Players in China (2019-2020)
8.3 China Mycoplasma Diagnostics Market Size by Type (2015-2020)
8.4 China Mycoplasma Diagnostics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Mycoplasma Diagnostics Market Size (2015-2020)
9.2 Mycoplasma Diagnostics Key Players in Japan (2019-2020)
9.3 Japan Mycoplasma Diagnostics Market Size by Type (2015-2020)
9.4 Japan Mycoplasma Diagnostics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Mycoplasma Diagnostics Market Size (2015-2020)
10.2 Mycoplasma Diagnostics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Mycoplasma Diagnostics Market Size by Type (2015-2020)
10.4 Southeast Asia Mycoplasma Diagnostics Market Size by Application (2015-2020)
11 India
11.1 India Mycoplasma Diagnostics Market Size (2015-2020)
11.2 Mycoplasma Diagnostics Key Players in India (2019-2020)
11.3 India Mycoplasma Diagnostics Market Size by Type (2015-2020)
11.4 India Mycoplasma Diagnostics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Mycoplasma Diagnostics Market Size (2015-2020)
12.2 Mycoplasma Diagnostics Key Players in Central & South America (2019-2020)
12.3 Central & South America Mycoplasma Diagnostics Market Size by Type (2015-2020)
12.4 Central & South America Mycoplasma Diagnostics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Agilent Technologies, Inc
13.1.1 Agilent Technologies, Inc Company Details
13.1.2 Agilent Technologies, Inc Business Overview
13.1.3 Agilent Technologies, Inc Mycoplasma Diagnostics Introduction
13.1.4 Agilent Technologies, Inc Revenue in Mycoplasma Diagnostics Business (2015-2020))
13.1.5 Agilent Technologies, Inc Recent Development
13.2 Thermo Fisher Scientific Inc
13.2.1 Thermo Fisher Scientific Inc Company Details
13.2.2 Thermo Fisher Scientific Inc Business Overview
13.2.3 Thermo Fisher Scientific Inc Mycoplasma Diagnostics Introduction
13.2.4 Thermo Fisher Scientific Inc Revenue in Mycoplasma Diagnostics Business (2015-2020)
13.2.5 Thermo Fisher Scientific Inc Recent Development
13.3 PromoCell GmbH
13.3.1 PromoCell GmbH Company Details
13.3.2 PromoCell GmbH Business Overview
13.3.3 PromoCell GmbH Mycoplasma Diagnostics Introduction
13.3.4 PromoCell GmbH Revenue in Mycoplasma Diagnostics Business (2015-2020)
13.3.5 PromoCell GmbH Recent Development
13.4 Charles River Laboratories International, Inc
13.4.1 Charles River Laboratories International, Inc Company Details
13.4.2 Charles River Laboratories International, Inc Business Overview
13.4.3 Charles River Laboratories International, Inc Mycoplasma Diagnostics Introduction
13.4.4 Charles River Laboratories International, Inc Revenue in Mycoplasma Diagnostics Business (2015-2020)
13.4.5 Charles River Laboratories International, Inc Recent Development
13.5 Merck KGaA
13.5.1 Merck KGaA Company Details
13.5.2 Merck KGaA Business Overview
13.5.3 Merck KGaA Mycoplasma Diagnostics Introduction
13.5.4 Merck KGaA Revenue in Mycoplasma Diagnostics Business (2015-2020)
13.5.5 Merck KGaA Recent Development
13.6 Lonza Group
13.6.1 Lonza Group Company Details
13.6.2 Lonza Group Business Overview
13.6.3 Lonza Group Mycoplasma Diagnostics Introduction
13.6.4 Lonza Group Revenue in Mycoplasma Diagnostics Business (2015-2020)
13.6.5 Lonza Group Recent Development
13.7 Takara Bio Inc (Takara Holding Company Inc.)
13.7.1 Takara Bio Inc (Takara Holding Company Inc.) Company Details
13.7.2 Takara Bio Inc (Takara Holding Company Inc.) Business Overview
13.7.3 Takara Bio Inc (Takara Holding Company Inc.) Mycoplasma Diagnostics Introduction
13.7.4 Takara Bio Inc (Takara Holding Company Inc.) Revenue in Mycoplasma Diagnostics Business (2015-2020)
13.7.5 Takara Bio Inc (Takara Holding Company Inc.) Recent Development
13.8 Savyon Diagnostics
13.8.1 Savyon Diagnostics Company Details
13.8.2 Savyon Diagnostics Business Overview
13.8.3 Savyon Diagnostics Mycoplasma Diagnostics Introduction
13.8.4 Savyon Diagnostics Revenue in Mycoplasma Diagnostics Business (2015-2020)
13.8.5 Savyon Diagnostics Recent Development
13.9 Tecan Trading AG (Tecan Group)
13.9.1 Tecan Trading AG (Tecan Group) Company Details
13.9.2 Tecan Trading AG (Tecan Group) Business Overview
13.9.3 Tecan Trading AG (Tecan Group) Mycoplasma Diagnostics Introduction
13.9.4 Tecan Trading AG (Tecan Group) Revenue in Mycoplasma Diagnostics Business (2015-2020)
13.9.5 Tecan Trading AG (Tecan Group) Recent Development
13.10 Sartorius Stedim BioOutsource Limited
13.10.1 Sartorius Stedim BioOutsource Limited Company Details
13.10.2 Sartorius Stedim BioOutsource Limited Business Overview
13.10.3 Sartorius Stedim BioOutsource Limited Mycoplasma Diagnostics Introduction
13.10.4 Sartorius Stedim BioOutsource Limited Revenue in Mycoplasma Diagnostics Business (2015-2020)
13.10.5 Sartorius Stedim BioOutsource Limited Recent Development
13.11 American Type Culture Collection (ATCC)
10.11.1 American Type Culture Collection (ATCC) Company Details
10.11.2 American Type Culture Collection (ATCC) Business Overview
10.11.3 American Type Culture Collection (ATCC) Mycoplasma Diagnostics Introduction
10.11.4 American Type Culture Collection (ATCC) Revenue in Mycoplasma Diagnostics Business (2015-2020)
10.11.5 American Type Culture Collection (ATCC) Recent Development
13.12 F Hoffmann-La Roche
10.12.1 F Hoffmann-La Roche Company Details
10.12.2 F Hoffmann-La Roche Business Overview
10.12.3 F Hoffmann-La Roche Mycoplasma Diagnostics Introduction
10.12.4 F Hoffmann-La Roche Revenue in Mycoplasma Diagnostics Business (2015-2020)
10.12.5 F Hoffmann-La Roche Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Mycoplasma Diagnostics Key Market Segments
Table 2. Key Players Covered: Ranking by Mycoplasma Diagnostics Revenue
Table 3. Ranking of Global Top Mycoplasma Diagnostics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Mycoplasma Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Kits & Reagents
Table 6. Key Players of Instruments
Table 7. Key Players of Software & Services
Table 8. Global Mycoplasma Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Mycoplasma Diagnostics Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Mycoplasma Diagnostics Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Mycoplasma Diagnostics Market Share by Regions (2015-2020)
Table 12. Global Mycoplasma Diagnostics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Mycoplasma Diagnostics Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Mycoplasma Diagnostics Market Growth Strategy
Table 18. Main Points Interviewed from Key Mycoplasma Diagnostics Players
Table 19. Global Mycoplasma Diagnostics Revenue by Players (2015-2020) (Million US$)
Table 20. Global Mycoplasma Diagnostics Market Share by Players (2015-2020)
Table 21. Global Top Mycoplasma Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mycoplasma Diagnostics as of 2019)
Table 22. Global Mycoplasma Diagnostics by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Mycoplasma Diagnostics Product Solution and Service
Table 25. Date of Enter into Mycoplasma Diagnostics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Mycoplasma Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 28. Global Mycoplasma Diagnostics Market Size Share by Type (2015-2020)
Table 29. Global Mycoplasma Diagnostics Revenue Market Share by Type (2021-2026)
Table 30. Global Mycoplasma Diagnostics Market Size Share by Application (2015-2020)
Table 31. Global Mycoplasma Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 32. Global Mycoplasma Diagnostics Market Size Share by Application (2021-2026)
Table 33. North America Key Players Mycoplasma Diagnostics Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Mycoplasma Diagnostics Market Share (2019-2020)
Table 35. North America Mycoplasma Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 36. North America Mycoplasma Diagnostics Market Share by Type (2015-2020)
Table 37. North America Mycoplasma Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 38. North America Mycoplasma Diagnostics Market Share by Application (2015-2020)
Table 39. Europe Key Players Mycoplasma Diagnostics Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Mycoplasma Diagnostics Market Share (2019-2020)
Table 41. Europe Mycoplasma Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Mycoplasma Diagnostics Market Share by Type (2015-2020)
Table 43. Europe Mycoplasma Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Mycoplasma Diagnostics Market Share by Application (2015-2020)
Table 45. China Key Players Mycoplasma Diagnostics Revenue (2019-2020) (Million US$)
Table 46. China Key Players Mycoplasma Diagnostics Market Share (2019-2020)
Table 47. China Mycoplasma Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 48. China Mycoplasma Diagnostics Market Share by Type (2015-2020)
Table 49. China Mycoplasma Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 50. China Mycoplasma Diagnostics Market Share by Application (2015-2020)
Table 51. Japan Key Players Mycoplasma Diagnostics Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Mycoplasma Diagnostics Market Share (2019-2020)
Table 53. Japan Mycoplasma Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Mycoplasma Diagnostics Market Share by Type (2015-2020)
Table 55. Japan Mycoplasma Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Mycoplasma Diagnostics Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Mycoplasma Diagnostics Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Mycoplasma Diagnostics Market Share (2019-2020)
Table 59. Southeast Asia Mycoplasma Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Mycoplasma Diagnostics Market Share by Type (2015-2020)
Table 61. Southeast Asia Mycoplasma Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Mycoplasma Diagnostics Market Share by Application (2015-2020)
Table 63. India Key Players Mycoplasma Diagnostics Revenue (2019-2020) (Million US$)
Table 64. India Key Players Mycoplasma Diagnostics Market Share (2019-2020)
Table 65. India Mycoplasma Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 66. India Mycoplasma Diagnostics Market Share by Type (2015-2020)
Table 67. India Mycoplasma Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 68. India Mycoplasma Diagnostics Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Mycoplasma Diagnostics Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Mycoplasma Diagnostics Market Share (2019-2020)
Table 71. Central & South America Mycoplasma Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Mycoplasma Diagnostics Market Share by Type (2015-2020)
Table 73. Central & South America Mycoplasma Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Mycoplasma Diagnostics Market Share by Application (2015-2020)
Table 75. Agilent Technologies, Inc Company Details
Table 76. Agilent Technologies, Inc Business Overview
Table 77. Agilent Technologies, Inc Product
Table 78. Agilent Technologies, Inc Revenue in Mycoplasma Diagnostics Business (2015-2020) (Million US$)
Table 79. Agilent Technologies, Inc Recent Development
Table 80. Thermo Fisher Scientific Inc Company Details
Table 81. Thermo Fisher Scientific Inc Business Overview
Table 82. Thermo Fisher Scientific Inc Product
Table 83. Thermo Fisher Scientific Inc Revenue in Mycoplasma Diagnostics Business (2015-2020) (Million US$)
Table 84. Thermo Fisher Scientific Inc Recent Development
Table 85. PromoCell GmbH Company Details
Table 86. PromoCell GmbH Business Overview
Table 87. PromoCell GmbH Product
Table 88. PromoCell GmbH Revenue in Mycoplasma Diagnostics Business (2015-2020) (Million US$)
Table 89. PromoCell GmbH Recent Development
Table 90. Charles River Laboratories International, Inc Company Details
Table 91. Charles River Laboratories International, Inc Business Overview
Table 92. Charles River Laboratories International, Inc Product
Table 93. Charles River Laboratories International, Inc Revenue in Mycoplasma Diagnostics Business (2015-2020) (Million US$)
Table 94. Charles River Laboratories International, Inc Recent Development
Table 95. Merck KGaA Company Details
Table 96. Merck KGaA Business Overview
Table 97. Merck KGaA Product
Table 98. Merck KGaA Revenue in Mycoplasma Diagnostics Business (2015-2020) (Million US$)
Table 99. Merck KGaA Recent Development
Table 100. Lonza Group Company Details
Table 101. Lonza Group Business Overview
Table 102. Lonza Group Product
Table 103. Lonza Group Revenue in Mycoplasma Diagnostics Business (2015-2020) (Million US$)
Table 104. Lonza Group Recent Development
Table 105. Takara Bio Inc (Takara Holding Company Inc.) Company Details
Table 106. Takara Bio Inc (Takara Holding Company Inc.) Business Overview
Table 107. Takara Bio Inc (Takara Holding Company Inc.) Product
Table 108. Takara Bio Inc (Takara Holding Company Inc.) Revenue in Mycoplasma Diagnostics Business (2015-2020) (Million US$)
Table 109. Takara Bio Inc (Takara Holding Company Inc.) Recent Development
Table 110. Savyon Diagnostics Business Overview
Table 111. Savyon Diagnostics Product
Table 112. Savyon Diagnostics Company Details
Table 113. Savyon Diagnostics Revenue in Mycoplasma Diagnostics Business (2015-2020) (Million US$)
Table 114. Savyon Diagnostics Recent Development
Table 115. Tecan Trading AG (Tecan Group) Company Details
Table 116. Tecan Trading AG (Tecan Group) Business Overview
Table 117. Tecan Trading AG (Tecan Group) Product
Table 118. Tecan Trading AG (Tecan Group) Revenue in Mycoplasma Diagnostics Business (2015-2020) (Million US$)
Table 119. Tecan Trading AG (Tecan Group) Recent Development
Table 120. Sartorius Stedim BioOutsource Limited Company Details
Table 121. Sartorius Stedim BioOutsource Limited Business Overview
Table 122. Sartorius Stedim BioOutsource Limited Product
Table 123. Sartorius Stedim BioOutsource Limited Revenue in Mycoplasma Diagnostics Business (2015-2020) (Million US$)
Table 124. Sartorius Stedim BioOutsource Limited Recent Development
Table 125. American Type Culture Collection (ATCC) Company Details
Table 126. American Type Culture Collection (ATCC) Business Overview
Table 127. American Type Culture Collection (ATCC) Product
Table 128. American Type Culture Collection (ATCC) Revenue in Mycoplasma Diagnostics Business (2015-2020) (Million US$)
Table 129. American Type Culture Collection (ATCC) Recent Development
Table 130. F Hoffmann-La Roche Company Details
Table 131. F Hoffmann-La Roche Business Overview
Table 132. F Hoffmann-La Roche Product
Table 133. F Hoffmann-La Roche Revenue in Mycoplasma Diagnostics Business (2015-2020) (Million US$)
Table 134. F Hoffmann-La Roche Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Mycoplasma Diagnostics Market Share by Type: 2020 VS 2026
Figure 2. Kits & Reagents Features
Figure 3. Instruments Features
Figure 4. Software & Services Features
Figure 5. Global Mycoplasma Diagnostics Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Diagnostic Laboratories Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Mycoplasma Diagnostics Report Years Considered
Figure 11. Global Mycoplasma Diagnostics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Mycoplasma Diagnostics Market Share by Regions: 2020 VS 2026
Figure 13. Global Mycoplasma Diagnostics Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Mycoplasma Diagnostics Market Share by Players in 2019
Figure 16. Global Top Mycoplasma Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mycoplasma Diagnostics as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Mycoplasma Diagnostics Revenue in 2019
Figure 18. North America Mycoplasma Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Mycoplasma Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Mycoplasma Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Mycoplasma Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Mycoplasma Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Mycoplasma Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Mycoplasma Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
HIV/AIDS診断の世界市場（～2026年） Market Analysis and Insights: Global HIV/AIDS Diagnostics Market The global HIV/AIDS Diagnostics market size is projected to reach US$ 2808.6 million by 2026, from US$ 2661.7 million in 2020, at a CAGR of 5.1%% during 2021-2026. Global HIV/AIDS Diagnostics Scope and Market Size HIV/AIDS Diagnostics …- 獣医分子診断の世界市場（～2026年） The molecular diagnostic is defined as a technique for used in the laboratory for to identify a disease or its predisposition stage by analyzing the DNA or RNA or other proteins in humans and animals. Rising prevalence of various animal diseases globally is expected to favor the veterinary molecular…
- 自己免疫疾患用体外診断（IVD）・ラボ開発検査の世界市場（～2026年） In vitro diagnostics (IVD) are tests on bodily samples like blood, tissue or urine. IVDs are used to detect diseases, conditions, or infections.LDT for autoimmune diseases are tests specially developed in laboratory testing some autoimmune diseases. The market growth is attributed to rising occurren…
- 尿路上皮がん診断の世界市場（～2026年） Urothelial Carcinoma or Transitional Cell Carcinoma encompasses cancer in different parts of urinary tract like kidney, bladder, ureters, and renal pelvis. The increasing trends of cigarette smoking is increasing the chances of urothelial carcinoma manifold. Market Analysis and Insights: Global Urot…
- 紙ベース診断の世界市場（～2026年） Paper diagnostics are paper-based diagnostic tests performed for the detection of various infectious diseases and food quality monitoring. The increasing prevalence of infectious and lifestyle associated diseases will be one of the major factors that will have a positive impact on the growth of the …